New drug combo targets cancer spread to the brain
NCT ID NCT07449481
Summary
This study is testing a combination of three drugs (utidelone, bevacizumab, and sometimes etoposide) to treat cancer that has spread to the brain from lung or breast tumors. It will involve 56 patients to see if this approach can shrink brain tumors and control the disease. The goal is to find a better systemic treatment for this serious complication of advanced cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.